<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <title>Declaration of interests</title>
 <p>JS has received grants from Janssen and AbbVie and personal fees from AbbVie, outside of the submitted work. ML has received personal fees from Abbvie, Gilead, MSD, Novartis, Daiichi-Sankyo, and Sanofi, outside of the submitted work. LN has received research grants from Takeda, Janssen, and Merck, outside of the submitted work. PM has received personal fees from Roche outside of the submitted work. VS has received non-financial support from Novartis and AbbVie outside of the submitted work. AD has received grants from Roche, Celgene, Gilead Kite, ADC Therapeutics, Acerta Pharma, and AstraZeneca, personal fees from Roche, Celgene, Incyte, Gilead Kite, Acerta Pharma, and AstraZeneca, and non-financial support from Roche, Acerta Pharma, and AstraZeneca, all outside of the submitted work. CPF has received honoraria for consultancy work and speaker fees from Roche and Adienne, outside of the submitted work. WO has received personal fees from Roche, Takeda, Pfizer, Servier, Kite Gilead, MSD, Novartis, Beigene, AstraZeneca, and Syneos outside of the submitted work. AML has received personal fees from Incyte, and has done research sponsored by Incyte, Novartis, Janssen, Abbvie, Roche, Celgene, Amgen, Bristol-Myers Squibb, Takeda, Pfizer, Beigene, Oncopeptides, Verastem, Karyopharm, Archigen, Biopharma, Morphosys, Fibrogen, and Onconova, all outside of the submitted work. EZ has received grants from AstraZeneca, Celgene, Janssen, Merck, and Roche, personal fees as a member of advisory boards from Beigene, Celgene, Incyte, Merck, Roche, Celltrion Healthcare, and Kyte, and travel grants from AbbVie and Roche, all outside of the submitted work. KC has received personal fees from Roche and Adienne outside of the submitted work. All other authors declare no competing interests.</p>
</ack>
